Início › Câncer Endometrial › Nova York

Ensaios clínicos de Câncer Endometrial em Nova York

69 estudos para Câncer Endometrial estão buscando participantes em locais em Nova York.

Cidades em Nova York

Texto oficial do estudo (Inglês)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Roswell Park Cancer Institute, Buffalo
Memorial Sloan Kettering Commack, Commack
Memorial Sloan Kettering Westchester, Harrison
e mais 8

RecrutandoFase 2

Todas as idades · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT05564377

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Columbia University Medical Center, New York
Memorial Sloan Kettering, New York

RecrutandoFase 1/2

Idades 12 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT04585750

A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

START New York Long Island LLC, Lake Success

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT06270706

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

Northwell Health Imbert Cancer Center, Bay Shore
Memorial Sloan Kettering Commack, Commack
Northwell Health Physician Partners at Flushing, Flushing
e mais 20

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 2 de out. de 2026 · NCT07198074

A Phase 1 Study of the Safety and Tolerability of CTX-10726

START New York, Lake Success

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 2 de out. de 2026 · NCT07419841

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

Roswell Park Cancer Institute IDS, Buffalo
Memorial Sloan Kettering Hospital, New York

RecrutandoFase 2

Idades 18 e acima · Todos os sexos · Atualizado em 1 de out. de 2026 · NCT06172478

Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer

The Woman's Health Pavilion, Howard Beach
The Woman's Health Pavilion, Westbury

RecrutandoEstudo observacional

Idades 18 e acima · Mulheres · Atualizado em 29 de set. de 2026 · NCT05051722

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

University of Rochester, Rochester
State University of New York Upstate Medical University, Syracuse
Wilmot Cancer Institute at Webster, Webster

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 28 de set. de 2026 · NCT05112601

Study of AVZO-021 in Patients With Advanced Solid Tumors

Avenzo Therapeutics Recruiting Site, Mineola
Avenzo Therapeutics Recruiting Site, New York

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 28 de set. de 2026 · NCT05867251

Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors

Research Site, New York
Research Site, New York

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 25 de set. de 2026 · NCT06218914

ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer

Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center, New York
e mais 1

Recrutando

Idades 18 e acima · Mulheres · Atualizado em 25 de set. de 2026 · NCT07270666

Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers

Columbia University Medical Center, New York
Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 1/2

Idades 18 e acima · Mulheres · Atualizado em 25 de set. de 2026 · NCT03564340

A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab

Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 1/2

Idades 18 e acima · Mulheres · Atualizado em 24 de set. de 2026 · NCT04590326

Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Roswell Park Cancer Institute, Buffalo
Mount Sinai Chelsea, New York
Mount Sinai Hospital, New York
e mais 4

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 24 de set. de 2026 · NCT05640999

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Research Site, Commack

RecrutandoFase 2

Idades de 18 a 130 · Todos os sexos · Atualizado em 23 de set. de 2026 · NCT05489211

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Columbia University, New York
NYU Langone Health, New York
Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

New York University (NYU) Langone Medical Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07114601

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

START New York-Long Island, Lake Success
Memorial Sloan Kettering Cancer Center (MSKCC), New York

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 22 de set. de 2026 · NCT07262619

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Memorial Sloan Kettering Cancer Center Head Neck Services, New York

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 21 de set. de 2026 · NCT05983432

A Study of Ivonescimab in People With Endometrial and Cervical Cancers

Memorial Sloan Kettering Suffolk- Commack (All Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
e mais 1

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 21 de set. de 2026 · NCT06925724

A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 6055), Mineola
Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 6004), New York
Memorial Sloan Kettering Cancer Center ( Site 6053), New York

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 17 de set. de 2026 · NCT06952504

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

NYU Langone Hospital - Long Island, Mineola
NYU Langone Health, New York
SUNY Upstate Medical University, Syracuse

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 17 de set. de 2026 · NCT06340568

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

Research Site, Commack

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 11 de set. de 2026 · NCT05123482

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

NYU Langone Hospital - Long Island Investigational Pharmacy, Mineola
Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 10 de set. de 2026 · NCT06293898

Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer

NYU Laura and Isaac Perlmutter Cancer Center - 34th Street, New York
Perlmutter CC NYU Langone LI, New York

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 9 de set. de 2026 · NCT07166094

A Study of Sofe-M in Participants With Selected Advanced Solid Tumors

NYU Langone Health - Long Island, Mineola
New York University (NYU) Clinical Cancer Center, New York
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 4 de set. de 2026 · NCT06400472

A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors

Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 3 de set. de 2026 · NCT06515613

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Research Site, New York

RecrutandoFase 3

Idades 18 e acima · Mulheres · Atualizado em 3 de set. de 2026 · NCT06989112

A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9

Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT07186842

A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 27 de ago. de 2026 · NCT07227168

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

Icahn School of Medicine at Mount Sinai, New York
Montefiore Einstein Comprehensive Cancer Center, The Bronx

RecrutandoFase 1

Idades 15 e acima · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT06276491

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York

RecrutandoFase 1/2

12 Months – 30 Years · Todos os sexos · Atualizado em 25 de ago. de 2026 · NCT04851119

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

Roswell Park Comprehensive Cancer Center, Buffalo

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 21 de ago. de 2026 · NCT06774963

A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma

Laura & Isaac Perlmutter Cancer Center, New York
Memorial Sloan-Kettering Cancer Center, New York
Mount Sinai Health System, New York
e mais 1

RecrutandoFase 2

Idades 18 e acima · Mulheres · Atualizado em 21 de ago. de 2026 · NCT05548296

A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.

Start - Ny, Long Island City
Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 18 de ago. de 2026 · NCT07470853

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Memorial Sloan Kettering Cancer Center, New York

RecrutandoFase 1/2

Idades 18 e acima · Todos os sexos · Atualizado em 17 de ago. de 2026 · NCT05919264

A Study of PHST001 in Advanced Solid Tumors

START Center for Cancer Research - Long Island New York, Lake Success
Mount Sinai, New York

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 12 de ago. de 2026 · NCT06840886

A Study of MGC026 in Participants With Advanced Solid Tumors

START-New York Long Island, Lake Success

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 11 de ago. de 2026 · NCT06242470

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Memorial Sloan Kettering Commack (All Protocol Activities), Commack
Memorial Sloan Kettering Westchester (All protocol activities), Harrison
Memorial Sloan Kettering Cancer Center, New York
e mais 1

RecrutandoEstudo observacional

Idades 18 e acima · Mulheres · Atualizado em 7 de ago. de 2026 · NCT04291612

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Roswell Park Comprehensive Care Center, Buffalo

RecrutandoFase 1

Idades 18 e acima · Todos os sexos · Atualizado em 5 de ago. de 2026 · NCT07444814

Fonte: ClinicalTrials.gov, dados obtidos em 5 de out. de 2026. Cada estudo define seus próprios critérios de elegibilidade; a equipe do estudo decide quem pode participar.